ChatDOC/OCRFlux-bench-single huggingface dataset:
Meeting of the Remuneration Committee shall be held at least once a year. One meeting of the Remuneration Committee was held during the Year. The attendance records of each member of the Remuneration Committee at the said meeting are as follows:-

Name of the Directors	Attendance/
Number of
Remuneration
Committee meetings
Executive Director
Mr. Chu King Tien	1/1
Independent non-executive Directors
Mr. Hui Kwok Wah (Chairman)	1/1
Mr. Ma Sai Yam	1/1

During the Year, the Remuneration Committee has, among other things, reviewed the remuneration package of the Directors and senior management of the Group and recommendation was made to the Board in relation to their remuneration package.

# Nomination Committee

The Company has established a nomination committee (the “Nomination Committee”) on 15 May 2015 with written terms of reference in compliance with the Listing Rules. The Nomination Committee comprises one executive Director namely, Mr. Chu King Tien and two independent non-executive Directors, namely, Mr. Hui Kwok Wah and Mr. Ma Sai Yam, with Mr. Chu King Tien being appointed as the chairman of the Nomination Committee.

The roles and functions of the Nomination Committee include, among other things, reviewing the structure, size and composition of the Board at least once a year, making recommendations on any proposed changes to the Board to complement the Company’s corporate strategy, identifying individuals suitably qualified to become members of the Board and selecting, or making recommendations to the Board on the selection of individuals nominated for directorships, assessing the independence of the independent non-executive Directors and making recommendations to the Board on the appointment or re-appointment of the Directors and succession planning for Directors, in particular the chairman and the chief executive officer.

The Nomination Committee shall meet at least once a year. One meeting of the Nomination Committee was held during the Year. The attendance records of each member of the Nomination Committee at the said meeting are as follows:-

Name of the Directors	Attendance/
Number of
Nomination
Committee meetings
Executive Director
Mr. Chu King Tien (Chairman)	1/1
Independent non-executive Directors
Mr. Hui Kwok Wah	1/1
Mr. Ma Sai Yam	1/1
During the Year, the Nomination Committee has, among other things, reviewed the structure, size, composition and diversity of the Board, considered the appointment or re-appointment of the Directors, reviewed the independent non-executive Directors’ annual confirmation on independence and assessed their independence. The Nomination Committee will continue to review the necessity of more competent staff to join in for the expansion of the Group.

Pursuant to the amended Mandatory Disclosure Requirement L.(d)(ii) in the Corporate Governance Report as contained in Appendix 14 of the Listing Rules the Company should disclose its policy for nomination of directors in the summary of work performed by the Nomination Committee in its corporate governance report.

# Nomination Criteria

In evaluating and selecting any candidate for the directorship, the following criteria should be considered:

• character and integrity;

• qualifications including professional qualifications, skills, knowledge and experience, and diversity aspects under the Board Diversity Policy that are relevant to the Company’s business and corporate strategy;

• any measurable objectives adopted for achieving diversity on the Board;

• for independent non-executive Directors, whether the candidate would be considered independent with reference to the independence guidelines set out in the Listing Rules;

• any potential contributions the candidate can bring to the Board in terms of qualifications, skills, experience, independence and gender diversity;

• willingness and ability to devote adequate time to discharge duties as a member of the Board and/or Board committee(s) of the Company; and

• such other perspectives that are appropriate to the Company’s business and succession plan and where applicable may be adopted and/or amended by the Board and/or the Nomination Committee from time to time for nomination of directors and succession planning.

# Nomination Procedures

The Company has put in place the following Director nomination procedures:

# Appointment of New and Replacement Directors

(i) If the Board determines that an additional or replacement Director is required, it will deploy multiple channels for identifying suitable director candidates, including referral from Directors, shareholders, management, advisors of the Company and external executive search firms.

(ii) Upon compilation and interview of the list of potential candidates, the Nomination Committee will shortlist candidates for consideration by the Nomination Committee and/or the Board based on the selection criteria and such other factors that it considers appropriate. The Board has the final authority on determining suitable director candidate for appointment.
# 46. FINANCIAL INSTRUMENTS (continued)

# b. Financial risk management objectives and policies (continued)

# Credit risk and impairment assessment (continued)

The Group invests in rated and unrated debt securities as well as investment grade debt securities. The management regularly reviews and monitors the portfolio of debt securities. Summary of the fair value and principal amount of debt securities at FVTPL are set out below.

# Debt securities at FVTPL

2021	2020
Fair value	Principal
amount	Fair value	Principal
amount
HK$’000	HK$’000	HK$’000	HK$’000
AA- to BBB-	166,806	163,726	422,637	455,245
BB+ to B	129,350	130,523	51,997	52,308
Unrated	89,139	87,291	242,602	242,602
385,295	381,540	717,236	750,155
# 46. FINANCIAL INSTRUMENTS (continued)

# b. Financial risk management objectives and policies (continued)

# Credit risk and impairment assessment (continued)

# Trade debtors and contract assets arising from contracts with customers as well as lease receivables

In order to minimise the credit risk, the management of the Group has policies in place to ensure the sales of properties are made to purchasers with an appropriate financial strength and appropriate percentage of down payments. Monitoring procedures are in place to ensure that follow-up action is taken to recover overdue debts. In addition, the Group performs impairment assessment under ECL model on trade debtors including lease receivables individually or collectively based on the Group’s internet credit rating. Contract assets are assessed on an individual basis for impairment purpose.

# Loan receivables/amounts due from associates, joint ventures, a shareholder of a non-wholly owned subsidiary and an investee company/bank balances and deposits

The credit risk of loan receivables and amounts due from associates, joint ventures, a shareholder of non-wholly owned subsidiary and an investee company is managed through an internal process. The Group actively monitors the outstanding amounts owed by each debtor and uses past due information to assess whether credit risk has increased significantly since initial recognition. The directors of the Company consider that the probability of default is minimal after assessing the counter-parties financial background and underlying assets held by the related parties.

Loan receivables represent mortgage loans secured by the properties of the borrowers.

In determining the recoverability of loan receivables, the Group considers any change in the credit quality of the borrowers, the value of the underlying properties under mortgage, historical settlements of loan interests and other forward-looking information.

# Debt instruments at FVTOCI

The Group only invests in debt securities with credit rating of B or above issued by Moody’s or Standard & Poor’s. The directors of the Company focus on the investment diversification and their credit ratings changes. The directors of the Company assess ECL on the debt instruments at FVTOCI based on the default rates published by major international credit rating agencies that are applicable to the respective debts instruments credit grades. As a result of this assessment, the directors of the Company are of the opinion that the ECL on these debt instruments is insignificant.

Summary of the fair value and principal amount of debt securities at FVTOCI are set out below.

2021	2020
Fair value	Principal
amount	Fair value	Principal
amount
HK$’000	HK$’000	HK$’000	HK$’000
AA- to BBB-	435,537	425,445	787,918	813,302
BB+ to B	1,259,538	1,274,442	647,113	906,070
Unrated	333,769	354,277	146,189	146,189
2,028,844	2,054,164	1,581,220	1,865,561

The credit risks on pledged deposits, restricted bank deposits, deposit in a financial institution, bank balances and deposits are limited because the counterparties are banks/financial institutions with high credit ratings assigned by international credit-rating agencies.
# ADDITIONAL KEY CORPORATE BANK DATA

Year ended December 31,	Change 2017 vs. 2016
dollars in millions	2017	2016	2015	Amount	Percent
NONINTEREST INCOME
Trust and investment services income	$ 138	$ 143	$ 137	$ (5)	(3.5)%
Investment banking and debt placement fees	589	471	439	118	25.1
Operating lease income and other leasing gains	80	56	62	24	42.9
Corporate services income	156	157	155	(1)	(.6)
Service charges on deposit accounts	50	50	43	—	—
Cards and payments income	40	29	15	11	37.9
Payments and services income	246	236	213	10	4.2
Mortgage servicing fees	61	53	48	8	15.1
Other noninterest income	33	54	27	(21)	(38.9)
Total noninterest income	$ 1,147	$ 1,013	$ 926	$ 134	13.2 %

# Other Segments

Other Segments consist of Corporate Treasury, our Principal Investing unit, and various exit portfolios. Other Segments generated net income attributable to Key of \$125 million for 2017, compared to \$89 million for 2016, and \$125 million for 2015.
# Revenue from major products

The following is an analysis of the Group’s revenue from its major products:

Year ended 31 December	Six months ended
30 June
2007	2008	2009	2009	2010
US$’000	US$’000	US$’000	US$’000	US$’000
(unaudited)
Deanxit ....................	26,144	36,710	44,468	22,768	26,029
Ursofalk ....................	14,756	21,074	28,327	13,393	16,937
Augentrofpen Stulln Mono edye-rops . .	3,011	4,394	6,146	2,817	3,814
GanFuLe....................	2,599	3,910	4,780	2,243	2,004
XinHuoSu ...................	—	2,839	7,253	2,983	5,697
Salofalk . . . . . . . . . . . . . . . . . . . .	—	133	1,824	658	1,684
Cystistat . . . . . . . . . . . . . . . . . . . .	—	66	515	171	319
Exacin ....................	—	—	—	—	3,367
Bioflor ....................	—	—	—	—	282
Others .....................	5,237	3,474	3,141	1,742	1,062
Total ......................	51,747	72,600	96,454	46,775	61,195

# 6. OTHER GAINS AND LOSSES

Year ended 31 December	Six months ended 30 June
2007	2008	2009	2009	2010
US$’000	US$’000	US$’000	US$’000	US$’000
(unaudited)
Service fee income . . . . . . . . . . . . . .	—	771	—	—	—
Net exchange gain (loss) . . . . . . . . . .	655	743	(405)	(272)	(109)
Government subsidies (Note) . . . . . . .	1	623	801	161	240
Interest income . . . . . . . . . . . . . . . .	236	221	329	94	302
Gain on disposal of a subsidiary . . . . .	—	—	24	—	—
Loss on disposal of an associate
(Note 18) . . . . . . . . . . . . . . . . .	—	—	(70)	—	—
Fair value change on investments held
for trading . . . . . . . . . . . . . . . . .	288	158	81	14	81
Imputed interest income on
available-for-sale investment . . . . . .	30	20	—	—	—
(Loss) gain on disposal of property,
lpant and equipment. . . . . . . . . . .	(8)	2	7	(2)	6
Impairment loss recognised on property,
lant and equipment (Note 14p) ....	—	—	(805)	—	—
Discount on acquisition of an associate
(Note 18) . . . . . . . . . . . . . . . . .	—	—	647	647	—
Others . . . . . . . . . . . . . . . . . . . . .	78	152	53	49	26
1,280	2,690	662	691	546

Note: The amount represents the incentive subsidies provided by the PRC local authorities to the Group to encourage performance of the research and development. There are no specific conditions attached to the grants, the Group recognised the grants upon receipts.
# 7. FINANCE COSTS

Year ended 31 December	Six months ended 30 June
2007	2008	2009	2009	2010
US$’000	US$’000	US$’000	US$’000	US$’000
(unaudited)
Interest on bank loans wholly repayable
within five years . . . . . . . . . . . . .	301	—	43	—	187
Imputed interest on deferred
consideration payables . . . . . . . . .	—	226	347	191	149
301	226	390	191	336

# 8. DIRECTORS’ AND EMPLOYEES’ EMOLUMENTS

Year ended 31 December	Six months ended 30 June
2007	2008	2009	2009	2010
US$’000	US$’000	US$’000	US$’000	US$’000
(unaudited)
Directors’ fees . . . . . . . . . . . . . . . .	188	193	161	77	81
Other emoluments to non-executive
directors and independent
non-executive directors .........	—	—	—	—	—
Other emoluments to executive
directors
- basic salaries and allowances . . . .	308	328	340	173	151
- retirement benefits scheme
contributions . . . . . . . . . . . . .	17	12	15	4	8
513	533	516	254	240
# 29. STATEMENT OF FINANCIAL POSITION AND RESERVE MOVEMENT OF THE COMPANY

# (a) Statement of financial position of the Company

As at 31 December
2018	2017
Note	HK$’000	HK$’000
ASSETS
Non-current assets
Investments in subsidiaries	2	25,196
Total non-current assets	2	25,196
Current assets
Trade and other receivables	1,458	1,708
Amounts due from subsidiaries	17,769	211,387
Bank and cash balances	82	319
Total current assets	19,309	213,414
TOTAL ASSETS	19,311	238,610
EQUITY AND LIABILITIES
Share capital	28	174,490	161,152
Reserves	29(b)	(166,895)	70,117
Total equity	7,595	231,269
LIABILITIES
Current liabilities
Amounts due to subsidiaries	8,657	437
Other payables and accruals	3,059	6,904
Total current liabilities	11,716	7,341
TOTAL EQUITY AND LIABILITIES	19,311	238,610

Approved by the Board of Directors on 29 March 2019 and is signed on its behalf by:

Zheng Jinwei	He Qian
# 29. STATEMENT OF FINANCIAL POSITION AND RESERVE MOVEMENT OF THE COMPANY (Continued)

# (b) Reserve movement of the Company

Share
premium	Share-based
payments
reserve	Convertible
bonds reserve	Contributed
surplus	Accumulated
losses	Total
HK$’000	HK$’000	HK$’000	HK$’000	HK$’000	HK$’000
At 1 January 2017	7,117,171	56,277	5,139	332,310	(7,395,273)	115,624
Loss for the year	—	—	—	—	(82,259)	(82,259)
Issue of shares by subscription
(note 28(b))	36,448	—	—	—	—	36,448
Redemption of convertible bonds	—	—	(5,139)	—	5,139	—
Share-based payments	—	304	—	—	—	304
Transfer of reserve upon lapse of
share options	—	(47,500)	—	—	47,500	—
At 31 December 2017	7,153,619	9,081	—	332,310	(7,424,893)	70,117
Adjustments on initial application of
— HKFRS 9	—	—	—	—	(203,603)	(203,603)
Restated balance at
1 January 2018	7,153,619	9,081	—	332,310	(7,628,496)	(133,486)
Loss for the year	—	—	—	—	(37,891)	(37,891)
Share-based payments	—	4,482	—	—	—	4,482
Issue of shares on share option
scheme	4,482	(4,482)	—	—	—	—
Transfer of reserve upon lapse of
share options	—	(9,081)	—	—	9,081	—
At 31 December 2018	7,158,101	—	—	332,310	(7,657,306)	(166,895)
# 1. Basis of Presentation

The Consolidated Financial Statements reflect the consolidated operations of TE Connectivity Ltd. and its subsidiaries and have been prepared in United States (‘‘U.S.’’) dollars in accordance with accounting principles generally accepted in the U.S. (‘‘GAAP’’).

# Description of the Business

TE Connectivity Ltd. (‘‘TE Connectivity’’ or the ‘‘Company,’’ which may be referred to as ‘‘we,’’ ‘‘us,’’ or ‘‘our’’) is a global technology and manufacturing leader creating a safer, sustainable, productive, and connected future. For more than 75 years, our connectivity and sensor solutions, proven in the harshest environments, have enabled advancements in transportation, industrial applications, medical technology, energy, data communications, and the home.

We operate through three reportable segments:

• Transportation Solutions. The Transportation Solutions segment is a leader in connectivity and sensor technologies. Our products, which must withstand harsh conditions, are used in the automotive, commercial transportation, and sensors markets.

• Industrial Solutions. The Industrial Solutions segment is a leading supplier of products that connect and distribute power, data, and signals. Our products are used in the industrial equipment; aerospace, defense, oil, and gas; and energy markets.

• Communications Solutions. The Communications Solutions segment is a leading supplier of electronic components for the data and devices and the appliances markets. We are also a leader in developing, manufacturing, installing, and maintaining some of the world’s most advanced subsea fiber optic communications systems.

# Use of Estimates

The preparation of the Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Significant estimates in these Consolidated Financial Statements include restructuring and other charges, assets acquired and liabilities assumed in acquisitions, allowances for doubtful accounts receivable, estimates of future cash flows and discount rates associated with asset impairments, useful lives for depreciation and amortization, loss contingencies, net realizable value of inventories, estimated contract revenue and related costs, legal contingencies, tax reserves and deferred tax asset valuation allowances, and the determination of discount and other rate assumptions for pension benefit cost. Actual results could differ materially from these estimates.

# Fiscal Year

We have a 52- or 53-week fiscal year that ends on the last Friday of September. For fiscal years in which there are 53 weeks, the fourth quarter reporting period includes 14 weeks. Fiscal 2017, 2016, and 2015 ended on September 29, 2017, September 30, 2016, and September 25, 2015, respectively. Fiscal 2017 and 2015 were 52 weeks in length. Fiscal 2016 was a 53-week year.
# CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

for the six months ended 30 September 2020 — unaudited

(Expressed in Hong Kong dollars)

Six months ended
30 September
2020	2019
$’000	$’000
(Loss)/profit for the period	(7,029)	18,425
Other comprehensive income for the period
Item that may be reclassified subsequently to
profit or loss:
Exchange difference on translation of the financial
statements of subsidiaries (nil tax effect)	7,554	(13,908)
Total comprehensive income for the period	525	4,517
# CONSOLIDATED STATEMENT OF FINANCIAL POSITION

at 30 September 2020 — unaudited

(Expressed in Hong Kong dollars)

Note	At
30 September
2020	At
31 March
2020
$’000	$’000
Non-current assets
Property, lipant and equpment	9	8,342	17,824
Intanilgbe assets	10	48,662	50,261
Goodwill	10	55,389	60,432
Deferred tax assets	2,307	2,097
114,700	130,614
Current assets
Inventories	747	927
Trade and other receivables	11	100,726	92,332
Current tax recoverable	3,265	—
Restricted bank deposits	2,878	2,586
Cash at bank and in hand	190,689	206,735
298,305	302,580
Current liabilities
Trade and other payables	12	117,484	100,687
Contract liabilities	47,897	45,349
Amount due to the controlling shareholder	3,459	2,435
Lease liabilities	12,557	21,054
Current tax payable	6,393	8,239
187,790	177,764
Net current assets	110,515	124,816
Total assets less current liabilities	225,215	255,430
# Noble Energy, Inc.

Consolidated Statements of Comprehensive Income (Loss)

(millions)

Year Ended December 31,
2017	2016	2015
Net Loss Including Noncontrolling Interests	$ (1,050)	$ (985)	$ (2,441)
Other Items of Comprehensive Loss
Net Change in Mutual Fund Investment	—	—	(11)
Less Tax Expense	—	—	4
Net Change in Pension and Other	3	3	99
Less Tax Benefit	(1)	(1)	(35)
Other Comprehensive Income	2	2	57
Comprehensive Loss Including Noncontrolling Interests	$ (1,048)	$ (983)	$ (2,384)
Less: Comprehensive Income Attributable to Noncontrolling Interests	68	13	—
Comprehensive Loss Attributable to Noble Energy	$ (1,116)	$ (996)	$ (2,384)

The accompanying notes are an integral part of these financial statements.
Noble Energy, Inc.

Consolidated Balance Sheets

(millions)

December 31,
2017	December 31,
2016
ASSETS
Current Assets
Cash and Cash Equivalents	$ 675	$ 1,180
Accounts Receivable, Net	748	615
Other Current Assets	780	160
Total Current Assets	2,203	1,955
Property, Plant and Equipment
Oil and Gas Properties (Successful Efforts Method of Accounting)	29,678	30,355
Property, Plant and Equipment, Other	879	909
Total Property, Plant and Equipment, Gross	30,557	31,264
Accumulated Delpreciation, DedApetion an mortization	(13,055)	(12,716)
Total Property, Plant and Equipment, Net	17,502	18,548
Goodwill	1,310	—
Other Noncurrent Assets	461	508
Total Assets	$ 21,476	$ 21,011
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts Payable ­ Trade	$ 1,161	$ 736
Other Current Liabilities	578	742
Total Current Liabilities	1,739	1,478
Long­Term Debt	6,746	7,011
Net Deferred Income Tax Liability	1,127	1,819
Other Noncurrent Liabilities	1,245	1,103
Total Liabilities	10,857	11,411
Shareholders’ Equity
Preferred Stock ­ Par Value $1.00 per share; 4 Million Shares Authorized, None Issued	—	—
Common Stock ­ Par Value $0.01; 1 Billion Shares Authorized; 529 Million and 471 Million
Shares Issued, Respectively	5	5
Additional Paid in Cailpta	8,438	6,450
Accumulated Other Comprehensive Loss	(30)	(31)
Treasury Stock, at Cost; 39 Million and 38 Million Shares, Respectively	(725)	(692)
Retained Earnings	2,248	3,556
Noble Energy Share of Equity	9,936	9,288
Noncontrolling Interests	683	312
Total Equity	10,619	9,600
Total Liabilities and Equity	$ 21,476	$ 21,011

The accompanying notes are an integral part of these financial statements.
# Statements of Changes in Equity

Year ended 31 December 2016

Company	Share
capital	Merger/
capital
reserve	Share-based
payments
reserve	Hedging
reserve	Retained
profits	Total
reserves	Total
equity
$m	$m	$m	$m	$m	$m	$m
At 1 January 2015	282.6	276.5	13.4	(1.4)	823.2	1,111.7	1,394.3
Total comprehensive income for the year
Profit for the year	–	–	–	–	514.9	514.9	514.9
Other comprehensive income
Effective portion of changes in fair value
of cash flow hedges, net of taxation	–	–	–	1.9	–	1.9	1.9
Total comprehensive income for the year	–	–	–	1.9	514.9	516.8	516.8
Transactions with equity holders of the Company,
recognised directly in equity
Contributions by and distributions to equity holders
of the Company
Issue of shares pursuant to share plans	10.9	–	(10.6)	–	–	(10.6)	0.3
Share-based payment expenses	–	–	9.5	–	–	9.5	9.5
Dividends paid (Note 29)	–	–	–	–	(345.9)	(345.9)	(345.9)
Total transactions with equity holders of the Company	10.9	–	(1.1)	–	(345.9)	(347.0)	(336.1)
At 31 December 2015	293.5	276.5	12.3	0.5	992.2	1,281.5	1,575.0
Financials

Company	Share
capital	Treasury
shares	Merger/
capital
reserve	Share-based
payments
reserve	Fair value
reserve	Hedging
reserve	Retained
profits	Total
reserves	Total
equity
$m	$m	$m	$m	$m	$m	$m	$m	$m
At 1 January 2016	293.5	–	276.5	12.3	–	0.5	992.2	1,281.5	1,575.0
Total comprehensive income for the year
Profit for the year	–	–	–	–	–	–	497.1	497.1	497.1
Other comprehensive income
Net change in fair value of
available-for-sale financial assets	–	–	–	–	12.5	–	–	12.5	12.5
Effective portion of changes in fair value
of cash flow hedges, net of taxation	–	–	–	–	–	(0.5)	–	(0.5)	(0.5)
Total comprehensive income
for the year	–	–	–	–	12.5	(0.5)	497.1	509.1	509.1
Transactions with equity holders of the
Company, recognised directly
in equity
Contributions by and distributions
to equity holders of the Company
Treasury shares purchased by the Company	–	(12.3)	–	–	–	–	–	(12.3)	(12.3)
Issue of shares pursuant to share plans	6.2	–	–	(6.2)	–	–	–	(6.2)	–
Share-based payment expenses	–	–	–	7.2	–	–	–	7.2	7.2
Tax impact on transfer of treasury shares	–	–	–	0.8	–	–	–	0.8	0.8
Dividends paid (Note 29)	–	–	–	–	–	–	(346.2)	(346.2)	(346.2)
Total transactions with equity holders
of the Company	6.2	(12.3)	–	1.8	–	–	(346.2)	(356.7)	(350.5)
At 31 December 2016	299.7	(12.3)	276.5	14.1	12.5	–	1,143.1	1,433.9	1,733.6